Guangzhou Wondfo Biotech Co.,Ltd

XSEC:300482 Stock Report

Market Cap: CN¥11.8b

Guangzhou Wondfo BiotechLtd Balance Sheet Health

Financial Health criteria checks 5/6

Guangzhou Wondfo BiotechLtd has a total shareholder equity of CN¥5.6B and total debt of CN¥564.0M, which brings its debt-to-equity ratio to 10.1%. Its total assets and total liabilities are CN¥6.8B and CN¥1.2B respectively. Guangzhou Wondfo BiotechLtd's EBIT is CN¥507.8M making its interest coverage ratio -96.7. It has cash and short-term investments of CN¥2.1B.

Key information

10.1%

Debt to equity ratio

CN¥564.03m

Debt

Interest coverage ratio-96.7x
CashCN¥2.11b
EquityCN¥5.57b
Total liabilitiesCN¥1.18b
Total assetsCN¥6.75b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300482's short term assets (CN¥3.8B) exceed its short term liabilities (CN¥504.8M).

Long Term Liabilities: 300482's short term assets (CN¥3.8B) exceed its long term liabilities (CN¥678.7M).


Debt to Equity History and Analysis

Debt Level: 300482 has more cash than its total debt.

Reducing Debt: 300482's debt to equity ratio has increased from 2.3% to 10.1% over the past 5 years.

Debt Coverage: 300482's debt is well covered by operating cash flow (95.4%).

Interest Coverage: 300482 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies